IL6 and gastric cancer: It was revealed by secretome and transcriptome analysis in GC that predominantly expressed secretory protein IL-6 was CAF-specific and clinical data suggested that IL-6 was linked with a poor response to chemotherapy, suggesting a possible role in chemoresistance [58].